Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
381
-
Total 13F shares, excl. options
-
166M
-
Shares change
-
+6.61M
-
Total reported value, excl. options
-
$16.9B
-
Value change
-
+$174M
-
Put/Call ratio
-
0.83
-
Number of buys
-
182
-
Number of sells
-
-184
-
Price
-
$104.76
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2015
470 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2015.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 381 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 166M shares
of 194M outstanding shares and own 85.89% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (18M shares), FMR LLC (14.6M shares), SANDS CAPITAL MANAGEMENT, LLC (11.6M shares), VANGUARD GROUP INC (11.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.03M shares), PRIMECAP MANAGEMENT CO/CA/ (7.33M shares), JENNISON ASSOCIATES LLC (6.69M shares), JPMORGAN CHASE & CO (5.63M shares), SABBY MANAGEMENT, LLC (5M shares), and BAKER BROS. ADVISORS LP (4.12M shares).
This table shows the top 381 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.